| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/01/2001 | CA2210875C Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides |
| 05/01/2001 | CA2186919C Therapeutic anti-inflammatory and analgesic pharmaceutical composition containing nimesulide 4-nitro, 2 phenoxyphenyl methane sulphonamide for use transdermally and a process for the manufacture thereof |
| 05/01/2001 | CA2150939C Stable protein: phospholipid compositions and methods |
| 05/01/2001 | CA2109368C A process for the non-ramdom cleavage of starch and the low d. e. starchconversion products produced therby |
| 05/01/2001 | CA2034926C Treatment of poisoning and compositions for use therein |
| 04/26/2001 | WO2001029244A1 Nucleic acid transporter containing polypeptide and recombinant virus vector |
| 04/26/2001 | WO2001029233A2 Chimeric immunogenic compositions and nucleic acids encoding them |
| 04/26/2001 | WO2001029184A1 Powdery compositions of liquid aureobasidium culture, process for producing the same and powdery mixtures by using these compositions |
| 04/26/2001 | WO2001029170A1 Protein-containing granules and granule formulations |
| 04/26/2001 | WO2001029056A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | WO2001029046A2 A salt of morphine |
| 04/26/2001 | WO2001028918A1 Controlled release of doxorubicin |
| 04/26/2001 | WO2001028673A1 Use of galactomannans as an emulsifying agent |
| 04/26/2001 | WO2001028603A1 Formulations for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028602A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | WO2001028600A1 Conveyance of anti-infective activity to wound dressings |
| 04/26/2001 | WO2001028595A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | WO2001028593A2 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | WO2001028592A1 Cobalamin conjugates useful as imaging agents and as antitumor agents |
| 04/26/2001 | WO2001028591A2 Injection vehicle for polymer-based formulations |
| 04/26/2001 | WO2001028590A2 PHARMACEUTICAL COMPOSITIONS CONTAINING N-[N-(3,3-DIMETHYLBUTYL)-1-α-ASPARTYL]-L-PHENYLALANINE METHYL ESTER |
| 04/26/2001 | WO2001028589A2 Shaped body comprising an amphiphilic outer phase and a lipophilic inner phase |
| 04/26/2001 | WO2001028587A2 Magnetic targeted carrier |
| 04/26/2001 | WO2001028585A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | WO2001028572A1 Iodine containing antimicrobial compositions for mastitis control |
| 04/26/2001 | WO2001028571A1 Stable preparations for treating bedsore, skin ulcer and wound |
| 04/26/2001 | WO2001028569A1 Targeted vectors |
| 04/26/2001 | WO2001028564A1 Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 04/26/2001 | WO2001028563A1 Ciclesonide-containing aqueous pharmaceutical composition |
| 04/26/2001 | WO2001028562A1 Ciclesonide contained pharmaceutical composition for application to mucosa |
| 04/26/2001 | WO2001028559A1 Method for stabilizing benzimidazole compounds |
| 04/26/2001 | WO2001028558A1 Formulation of substituted benzimidazoles |
| 04/26/2001 | WO2001028556A2 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 04/26/2001 | WO2001028552A2 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/26/2001 | WO2001028544A2 Dialysis solution including polyglycol osmotic agent |
| 04/26/2001 | WO2001028538A2 Laxative preparation containing l-arginine |
| 04/26/2001 | WO2001028531A1 Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin |
| 04/26/2001 | WO2001028530A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 04/26/2001 | WO2001028529A1 Pharmaceutical products and methods of fabrication therefor |
| 04/26/2001 | WO2001028527A2 Direct compression polymer tablet core |
| 04/26/2001 | WO2001028525A2 Method of producing sub-micron particles of biologically active agents |
| 04/26/2001 | WO2001028523A1 Powder pharmaceutical formulations |
| 04/26/2001 | WO2001028522A2 Method for producing liposome preparation |
| 04/26/2001 | WO2001028521A2 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/26/2001 | WO2001028520A1 Microemulsion preconcentrates, microemulsion and use of such a composition |
| 04/26/2001 | WO2001028519A1 Microemulsion preconcentrates and microemulsions |
| 04/26/2001 | WO2001028518A1 Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions |
| 04/26/2001 | WO2001028517A1 Aqueous medicinal compositions |
| 04/26/2001 | WO2001028516A2 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | WO2001028515A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | WO2001028494A2 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 04/26/2001 | WO2001028492A2 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | WO2001028472A1 Drug delivery device |
| 04/26/2001 | WO2001028336A1 A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties |
| 04/26/2001 | WO2000069415A3 Melt granulation |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000061121A3 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy |
| 04/26/2001 | WO2000059447A3 Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 04/26/2001 | WO2000057869A3 Viral treatment |
| 04/26/2001 | WO1997034932A3 Compositions containing starch excipients |
| 04/26/2001 | US20010000510 Electrostatic bonding type macromolecular micelle drug carrier and carried thereon |
| 04/26/2001 | US20010000471 Active medicament such as dimenhydrinate, an inner oil substance coating of given melting point, such as soybean oil, and outer coating layer of a polymeric substance such as ethyl cellulose; free of bad tastes |
| 04/26/2001 | US20010000470 Matrix of a biocompatible polymer and a drug, having a hydrophobic or amphiphilic compound to modify the diffusion of water into the matrix and the release of the drug; prolongs degradation of hydrolytically unstable polymers |
| 04/26/2001 | US20010000468 Hydroxyalkyl arabinogalactan, carboxymethyl arabinogalactan, quaternary ammonium arabinogalactan, carboxymethyl arabinogalactan, or a combinations thereof; does not impart negative rheological effects to personal care compositions |
| 04/26/2001 | DE19950066A1 Transdermal therapeutic system based on polyacrylate matrix carrier comprises tulobuterol hydrochloride |
| 04/26/2001 | DE19949252A1 Superfizielles therapeutisches System zur topischen Applikation von Acetylsalicylsäure zur Behandlung von Akne-Erkrankungen Superficial therapeutic system for the topical application of acetylsalicylic acid for the treatment of acne diseases |
| 04/26/2001 | DE19946822A1 Wirk- und/oder Hilfsstoffe enthaltende Zubereitung mit steuerbarer Freisetzung dieser Stoffe, sowie ihre Verwendung und Herstellung Active and / or adjuvants containing preparation with controllable release of these substances, and their use and production |
| 04/26/2001 | DE10032444A1 Enteral feeding solutions contain an alkyl paraben to inhibit growth of micro-organisms in the enteral tube |
| 04/26/2001 | CA2388700A1 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | CA2388653A1 Method of producing sub-micron particles of biologically active agents |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2388166A1 Microcapsules for stabilizing cosmetic, pharmaceutical or food products |
| 04/26/2001 | CA2387925A1 Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
| 04/26/2001 | CA2387819A1 Sustained-release formulations for treating cns-mediated disorders |
| 04/26/2001 | CA2387767A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | CA2387757A1 Cobalamin conjugates useful as imaging agents and as antitumor agents |
| 04/26/2001 | CA2387558A1 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | CA2387511A1 Protein-containing granules and granule formulations |
| 04/26/2001 | CA2386937A1 Iodine containing antimicrobial compositions for mastitis control |
| 04/26/2001 | CA2386626A1 Targeted vectors |
| 04/26/2001 | CA2386422A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 04/26/2001 | CA2386408A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 04/26/2001 | CA2386155A1 Method for producing liposome preparation |
| 04/26/2001 | CA2386143A1 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/26/2001 | CA2384844A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | CA2382985A1 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 04/26/2001 | CA2382978A1 Powder pharmaceutical formulations |
| 04/26/2001 | CA2382864A1 Dialysis solution including polyglycol osmotic agent |
| 04/26/2001 | CA2356177A1 Aqueous pharmaceutical compositions |
| 04/25/2001 | EP1094073A2 Analogs of PTH and PTHRP, their synthesis and use for the treatment of osteoporosis |
| 04/25/2001 | EP1094065A2 Cucurbituril derivatives, their preparation methods and uses |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP1093818A1 Powdery preparation for mucosal administration containing polymeric medicine |
| 04/25/2001 | EP1093816A2 Use of ST1435 in hormonal therapy by transdermal application |
| 04/25/2001 | EP1093815A1 Oral 2-methyl-thieno-benzodiazepine formulation |
| 04/25/2001 | EP1093813A2 Process for preparing polymer coated tablet comprising amoxycillin and clavunalate, coated with an aqueous polymeric filmcoating |
| 04/25/2001 | EP1093810A1 Fast-dissolving tablet comprising brotizolam |
| 04/25/2001 | EP1093797A1 Process for the photostabilisation of sunscreens derived from dibenzoylmethane by an insoluble organic filter |
| 04/25/2001 | EP1093469A1 Linear cyclodextrin copolymers |
| 04/25/2001 | EP1093468A1 Polymers for delivering nitric oxide in vivo |